细胞治疗的自动化市场:技术，治疗方法，策略，预测

本报告提供全球细胞治疗的自动化市场相关调查，市场概要，以及各市场区隔的技术趋势，市场影响要素，及加入此市场的主要企业简介等资讯。

目录

摘要整理

电池单元自动化技术

• 市场区隔
• 竞争技术
• 生物反应器
• 微电信业者
• 人口统计与成长
• 推动市场要素
• 危险因素

细胞培养监测

• 探针为基础的感测器
  • 电化学感测器
  • 光化学感测器系统
• 胶囊技术
• 抛弃式感测器贴片
• 品管
  • CMC
  • 光谱感测器
• 技术课题
• 电子干涉

实行技术

• 自主感应技术
• 无线资料传送
• 检体浓度
• 技术的限制

自动细胞疗法製造平台

• 下一代平台

市场要素

• 法规
  • FDA
  • GMP

企业简介

“ Cell Therapy Automation: Technologies, Therapeutics, Strategies & Forecasts ” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this growing oncolytic segment of the immunological therapy sector. The report has been designed and developed to provide pharmaceutical company decision makers, drug developers and formulators, device designers, and industry strategists with a detailed understanding of the expanding impact of cell therapy on pharmaceutical strategies and healthcare treatment protocols. Provider organization business managers, healthcare administrators and investors will also benefit from this publication.

Converging Factors Driving Cell Therapy Developments

Cell therapy has emerged as a promising new approach to treat malignancies that could only be treated on a palliative basis. Among those therapies, chimeric antigen receptor (CAR) modified T cell therapies has proved to be effective for hematological malignancies. To generate CAR T cells, patient- (autologous) or donor-derived (allogeneic) T cells are modified to express a CAR. The CAR is a chimeric construct containing at least one signaling domain of the T cell receptor and a single chain variable fragment (scFv).

The production of autologous CAR T cells is carried out by a variety of manufacturing approaches all comprising the same common steps. First, the patient's white blood cells (WBCs) are isolated by leukapheresis and washed. Then, the T cells are activated, transduced with the CAR transgene, expanded to the required cell numbers for therapy, formulated and filled. After quality control testing and preparatory lymphodepleting chemotherapy for the patient, the product is injected into the patient.

What You Will Learn:

• What current treatments are supplied as cell therapy treatments, how are they administered, what are the specifics, and who markets them?

• What cell Therapy treatments are in development, who are the developers, and what indications are they targeting?

• What are the major factors driving cell therapy demand?

• What is the size of the market today, who are the market share leaders, and what will the market share be in 2028?

• How important are drug developer relationships and what are the key alliances in the industry?

• What are the essential tech factors, technologies and market development issues for cell therapy products?

• What are the significant economic, technology, and regulatory factors affecting the market for cell therapy treatments?

Table of Contents

Executive Summary

Cell Automation Technologies

• Market Segments
• Competing Technologies
• Bioreactors
• Microcarriers
• Demographics and Growth
• Market Drivers
• Risk Factors

Cell Culture Monitoring

• Probe Based Sensors
  • Electrochemical Sensor
  • Optical Chemosensor Systems

• Capsule Technology
• Disposable Sensor Patches

• Quality Control
  • CMC
  • Spectroscopic Sensors

• Technical Challenges
• Electronic Interference

Enabling Technology

• Autonomous Sensor Technology
• Wireless Data Transmission

• Analyte Concentration
  • Photoluminescence Intensity
  • Absorption

• Technical Limitations
  • Electronic Interference

Automated Cell Therapy Manufacturing Platforms

• Next Generation Platforms
  • Cell Therapy Process Convergence
  • CT Process Standardization
  • Robotics

Market Factors

• Regulations
  • FDA
  • GMP

Company Profiles